Intellect Neurosciences, Inc.
| OTC Markets: ILNS
Intellect Neurosciences, Inc. is a biopharmaceutical company that is engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease and other neurodegenerative diseases especially focuses on proteinopathies. Its pipeline includes therapeutic vaccines, antibodies and neuroprotective antibody drug conjugates. The company was founded by Daniel G. Chain on April 25, 2005 and is headquartered in New York, NY.